FDA 483 - Children's National Medical Center IRB - May 20, 2025

The FDA inspected Children's National Medical Center IRB in Washington, DC, from May 12-20, 2025. The inspection revealed that the IRB did not ensure informed consent documents contained all necessary elements, specifically the required clinicaltrials.gov statement for a pediatric study. This indicates a deficiency in the IRB's oversight of clinical trial protocols.